Abstract
There is now a large amount of information from both clinical and experimental studies that indicate that there is a strong inverse correlation between tumor mass and potential curability by drugs (Skipper 1978; DeVita 1983). All other things being equal small tumor burdens will be much more susceptible to drug-induced cure than will large. This has been shown for a wide variety of transplanted rodent tumors and, as well, the same inference can be clearly made from clinical observation. For those disseminated malignancies for which curative chemotherapy is available, there appear to be no exceptions to the general statement that patients presenting with a significantly lower tumor burden are much more likely to achieve cure than those patients with the same histological disease who present with very extensive tumor burdens (Frei 1982). The extension of these concepts into the area of the treatment of more refractory groups of malignancies yields the conclusion that it may be possible to achieve drug-induced cures in patients with microscopic tumor burdens whereas the same disease at an advanced stage would be incurable. It is this hypothesis which has now become the underlying rationale for the utilization of so-called adjuvant chemotherapy.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Buick RN, Mackillop WJ (1981) Measurement of self-renewal in culture of clonogenic cells from human ovarian carcinoma. Br J Cancer 44: 349–355
Bush RS, Hill RP (1975) Biologic discussion augmenting radiation effects in model systems. Laryngoscope 85: 1119–1133
Bush RS, DeBoer G, Hill RP (1982) Long term survival with gynecological cancer. In: Stoll BA (ed) Prolonged arrest of cancer. Wiley, New York, pp 27–58
Coldman AJ, Goldie JH (1983) A model for the resistance of tumor cells to cancer chemotherapeutic agents. Math Biosci 65: 291–307
De Vita VT Jr (1983) The relationship between tumor mass and resistance to chemotherapy. Cancer 51: 1209–1220
Frei E III (1982) The National Cancer Chemotherapy Program. Science 217: 600–606
Goldie JH, Coldman AJ (1979) A mathematic model for relating the drug sensitivity of tumors to their spontaneous mutation rate. Cancer Treat Rep 63: 1727–1733
Goldie JH, Coldman AJ (1983) Quantitative model for multiple levels of drug resistance in clinical tumors. Cancer Treat Rep 67: 923–931
Schackney SE, McCormack GW, Cuchural GJ Jr (1978) Growth rate patterns of solid tumors and their relation to responsiveness to therapy: an analytical review. Ann Intern Med 89: 107–121
Simpson-Herren L, Sanford AH, Holmquist JP (1976) Effects of surgery on the cell kinetics of residual tumor. Cancer Treat Rep 60: 1749–1760
Skipper HE (1978) Cancer chemotherapy. I: Reasons for success and failure of treatment of murine leukemias with the drugs now employed treating human leukemias. University Microfilms, Ann Arbor
Skipper HE, Schabel FM Jr, Wilcox WS (1964) Experimental evaluation of potential anticancer agents. XII: On the criteria and kinetics associated with “curability” of experimental leukemia. Cancer Chemother Rep 35: 1–111
Steel GG, Lamerton LF (1968) Cell population kinetics and chemotherapy. Natl Cancer Inst Monogr 30: 29–50
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1986 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Goldie, J.H., Coldman, A.J. (1986). Theoretical Considerations Regarding the Early Use of Adjuvant Chemotherapy. In: Ragaz, J., Band, P.R., Goldie, J.H. (eds) Preoperative (Neoadjuvant) Chemotherapy. Recent Results in Cancer Research, vol 103. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-82671-9_3
Download citation
DOI: https://doi.org/10.1007/978-3-642-82671-9_3
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-82673-3
Online ISBN: 978-3-642-82671-9
eBook Packages: Springer Book Archive